Rosa M. De Miguel

Paseo De La Castellana 261, Madrid. CP 28046
Castellana, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

GeoSentinel Analysis of Travelers' Diarrhea Antimicrobial Resistance Patterns.

GeoSentinel Analysis of Travelers' Diarrhea Antimicrobial Resistance Patterns.

Journal: JAMA network open

Published: January 27, 2026

Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial.

Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial.

Journal: EClinicalMedicine

Published: November 26, 2025

Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.

Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 19, 2025

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.

Journal: HIV medicine

Published: August 20, 2025

Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients.

Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: July 13, 2025

Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIV.

Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIV.

Journal: AIDS and behavior

Published: April 29, 2025

Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial.

Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 12, 2024

Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Journal: Open forum infectious diseases

Published: August 21, 2024

Partial Recovery of Telomere Length After Long-term Virologic Suppression in Persons With HIV-1.

Partial Recovery of Telomere Length After Long-term Virologic Suppression in Persons With HIV-1.

Journal: Open forum infectious diseases

Published: August 16, 2024

Clinical profile and management of a Spanish single-center retrospective cohort of patients with post-chikungunya associated complications.

Clinical profile and management of a Spanish single-center retrospective cohort of patients with post-chikungunya associated complications.

Journal: Travel medicine and infectious disease

Published: October 17, 2023

Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.

Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.

Journal: Microorganisms

Published: June 12, 2023

Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.

Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.

Journal: HIV medicine

Published: March 06, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026